FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine and describes composition of 6-decaprenyl-2,3-dimethoxy-5-methyl-1,4-benzoquinone, which contains 0.2-15% 6-decaprenyl-2,3-dimethoxy-5-methyl-1,4-benzoquinone, 0.2-40% solubilising agent and 45-99.6% water.
EFFECT: composition has high bio-availability, quickness of action and accuracy of dosing.
10 cl, 2 dwg, 2 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| UBIQUINOL COMPOSITION FOR PARENTERAL ADMINISTRATION AND METHOD FOR ITS PRODUCTION | 2016 |
|
RU2635993C1 |
| 6-DECAPRENYL-2,3-DIMETHOXY-5-METHYL-1,4-BENZOQUINONE-BASE STABLE AQUEOUS-OILY COMPOSITION AND METHOD FOR ITS PREPARING | 2005 |
|
RU2290176C1 |
| 6-DECAPRENYL-2,3-DIMETHOXY-5-METHYL-1,4-BENZOQUINONE COMPOSITION AND METHOD FOR PREPARING IT | 2010 |
|
RU2445079C2 |
| COMPOSITION ON BASIS OF 6-DEKAPRENIL-2,3-DIMETOXY-5-METHYL-1,4-BENZOQUINONE FOR INJECTION INTRODUCTION IN ORGANISM AND WAY OF ITS OBTAINING | 2007 |
|
RU2359665C2 |
| COMPOSITION BASED ON 6-DECAPREENYL-2,3-DIMETHOXY-5-METHYL-1,4-BENZOCHINON AND METHOD TO OBTAIN IT | 2008 |
|
RU2405543C2 |
| LIPOSOMAL AGENT BASED ON UBIQUINOL AND PREPARATION METHOD THEREOF | 2015 |
|
RU2605616C1 |
| NOVEL OPTICALLY ACTIVE 4-HYDROXY-2-AZA-9,10-ANTHRAQUINONES, HAVING ANTIINFLAMMATORY ACTIVITY, AND SYNTHESIS METHOD THEREOF | 2010 |
|
RU2436775C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF SOLUTION FOR INJECTIONS OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE AND PYRIDOXIN, METHOD OF ITS OBTAINING AND METHOD OF TREATMENT | 2008 |
|
RU2383331C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF SOLUTION FOR INJECTIONS, POSSESSING CEREBROVASODILATING AND NOOTROPIC ACTIVITY, AND METHOD OF ITS RECEPTION | 2007 |
|
RU2359669C1 |
| METHOD OF PRODUCING A MEDICINAL PREPARATION FOR PARENTERAL APPLICATION | 2020 |
|
RU2739247C1 |
